Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review)
Author(s) -
Mariana Cornelia Tilinca,
Robert Aurelian Tiucă,
Cristiiculas,
Andreea Varga,
Ioan Ţilea
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10601
Subject(s) - semaglutide , molecular medicine , agonist , glucagon like peptide 1 receptor , receptor , oncogene , glucagon like peptide 1 , medicine , cancer research , biology , cell cycle , cancer , endocrinology , diabetes mellitus , type 2 diabetes , liraglutide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom